搜索页_+Panitumumab

设为首页

收藏本站

网站地图 | English | 公务邮箱

读者指南

学术客户端

NSTL服务站

科技查新

外文资源

Elsevier电子期刊(211)

在“Elsevier电子期刊”中，命中：211条，耗时：0.0249894 秒

在所有数据库中总计命中：211条

1.Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6)

作者：Jolie Ringash^a ; ^{jolie.ringash@rmp.uhn.on.ca} ; John N. Waldron^a ; Lillian L. Siu^a ; Rosemary Martino^b ; Eric Winquist^c ; Jim R. Wright^d ; Abdenour Nabid^e ; John H. Hay^f ; Alex Hammond^c ; Khalil Sultanem^g ; Sebastien Hotte^d ; Carson Leong^h ; Ali Abdel Halim El-Gayedⁱ ; Farah Naz^j ; Kevin Ramchandar^k ; Timothy E. Owen^l ; Alexander Montenegro^m ; Brian O'Sullivan^a ; Bingshu E. Chen^m ; Wendy R. Parulekar^m

关键词：Randomised clinical trial ; Phase III clinical trial ; Head and neck neoplasms ; Intensity-modulated radiation therapy ; Cisplatin ; Concurrent chemoradiotherapy ; Quality of life ; Swallowing ; Patient-reported outcomes

刊名：European Journal of Cancer

出版年：2017

2.The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials

作者：Julian Walter Holch^a ; ^b ; ^{julian.holch@med.uni-muenchen.de} ; Ingrid Ricard^c ; ^{ricard@ibe.med.uni-muenchen.de} ; Sebastian Stintzing^a ; ^b ; ^{sebastian.stintzing@med.uni-muenchen.de} ; Dominik Paul Modest^a ; ^b ; ^{dominik.modest@med.uni-muenchen.de} ; Volker Heinemann^a ; ^b ; ^{volker.heinemann@med.uni-muenchen.de}

关键词：Metastatic colorectal cancer ; Primary tumour location ; Sidedness ; Prognostic biomarker ; Predictive biomarker ; Cetuximab ; Panitumumab ; Bevacizumab ; Anti-EGFR ; Anti-VEGF

刊名：European Journal of Cancer

出版年：2017

3.Panitumumab-Induced Immune Complex Glomerulonephritis

作者：Hassan Izzedine ; MD ; PhD¹ ; ^{hassan.izzedine@clinique-monceau.com} ; Haide Boostandoost ; MD² ; Alexis Mathian ; MD ; PhD³

刊名：American Journal of Kidney Diseases

出版年：2017

4.Economic Analysis of Panitumumab Compared With Cetuximab in Patients With Wild-type KRAS Metastatic Colorectal Cancer That Progressed After Standard Chemotherapy

作者：Christopher N. Graham ; MS¹ ; ^{cgraham@rti.org" class="auth_mail" title="E-mail the corresponding author} ; Gregory A. Maglinte ; PhD² ; Lee S. Schwartzberg ; MD ; FACP³ ; Timothy J. Price ; MBBS ; DHlthSc (Medicine) ; FRACP⁴ ; Hediyyih N. Knox ; MA¹ ; ^{hknox@rti.org" class="auth_mail" title="E-mail the corresponding author} ; Guy Hechmati ; MD ; MSc⁵ ; Jonas Hjelmgren ; MSc⁵ ; Beth Barber ; PhD² ; Marwan G. Fakih ; MD⁶

关键词：cetuximab ; colorectal cancer ; cost-effectiveness ; cost-minimization ; panitumumab ; subsequent-line

刊名：Clinical Therapeutics

出版年：2016

5.Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial

作者：Denise A. Yardley¹ ; ² ; ^{dyardley@tnonc.com" class="auth_mail" title="E-mail the corresponding author} ; Patrick J. Ward¹ ; ³ ; Brooke R. Daniel¹ ; ⁴ ; Janice F. Eakle¹ ; ⁵ ; Ruth E. Lamar¹ ; ² ; Cassie M. Lane¹ ; John D. Hainsworth¹ ; ²

关键词：Chemotherapy ; EGFR inhibitor ; Metastatic breast cancer ; Panitumumab ; Triple-negative breast cancer

刊名：Clinical Breast Cancer

出版年：2016

6.Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer

作者：Timothy Price^a ; ^{timothy.price@sa.gov.au" class="auth_mail" title="E-mail the corresponding author} ; Tae Won Kim^b ; Jin Li^c ; Stefano Cascinu^d ; Paul Ruff^e ; Attili Satya Suresh^f ; Anne Thomas^g ; Sergei Tjulandin^h ; Xuesong Guanⁱ ; Marc Peeters^j

关键词：Anti-EGFR therapy ; Colorectal cancer ; Gastrointestinal cancer ; Panitumumab

刊名：European Journal of Cancer

出版年：2016

7.Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study

作者：Elvira del Barco Morillo^a ; Ricard Mesí ; a^b ; Juan Carlos Adansa Klain^a ; Silvia Vá ; zquez Ferná ; ndez^b ; Joaquina Martí ; nez-Galá ; n^c ; Miguel Pastor Borgoñ ; on^d ; Cyntia Gonzá ; lez-Rivas^c ; Javier Caballero Daroqui^d ; Alfonso Berrocal^e ; Javier Martí ; nez-Trufero^f ; Ruth Vera^g ; Juan Jesú ; s Cruz-Herná ; ndez^a ; ^{ttcc@seom.org" class="auth_mail" title="E-mail the corresponding author} ; on behalf of the Spanish Head And Neck Cancer Cooperative Group (TTCC)

关键词：Squamous cell carcinoma ; Head and neck cancer ; Recurrent ; Metastatic ; Panitumumab ; Paclitaxel

刊名：Oral Oncology

出版年：2016

8.PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck

作者：Lori J. Wirth^a ; ^{lwirth@mgh.harvard.edu" class="auth_mail" title="E-mail the corresponding author} ; Shaker Dakhil^b ; Gabriela Kornek^c ; Rita Axelrod^d ; Douglas Adkins^e ; Shubham Pant^f ; Paul O&rsquo ; Brien^g ; Philip R. Debruyne^h ; ⁱ ; Kelly S. Oliner^j ; Jun Dong^j ; Swami Murugappan^j

关键词：Head and neck cancer ; Squamous cell carcinoma ; Panitumumab ; Anti-EGFR therapy ; Docetaxel/cisplatin ; Human papillomavirus (limit 1&ndash ; 10)

刊名：Oral Oncology

出版年：2016

9.A review and assessment of currently available data of the EGFR antibodies in elderly patients with metastatic colorectal cancer

作者：Gerardo Rosati^a ; ^{oncogerry@yahoo.it" class="auth_mail" title="E-mail the corresponding author} ; Giuseppe Aprile^b ; Giovanni Gerardo Cardellino^b ; Antonio Avallone^c

关键词：Cetuximab ; Elderly ; Metastatic colorectal cancer ; Panitumumab ; Review

刊名：Journal of Geriatric Oncology

出版年：2016

10.A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type metastatic colorectal cancer

作者：Volker Heinemann^a ; ^{Volker.Heinemann@med.uni-muenchen.de" class="auth_mail" title="E-mail the corresponding author} ; Fernando Rivera^b ; ^{oncrhf@humv.es" class="auth_mail" title="E-mail the corresponding author} ; Bert H. O'Neil^c ; ^{bhoneil@iu.edu" class="auth_mail" title="E-mail the corresponding author} ; Sebastian Stintzing^a ; ^{Sebastian.Stintzing@med.uni-muenchen.de" class="auth_mail" title="E-mail the corresponding author} ; Reija Koukakis^d ; ^{reijak@amgen.com" class="auth_mail" title="E-mail the corresponding author} ; Jan-Henrik Terwey^e ; ^{jan-henrik.terwey@amgen.com" class="auth_mail" title="E-mail the corresponding author} ; Jean-Yves Douillard^f ; ^{jean-yves.douillard@esmo.org" class="auth_mail" title="E-mail the corresponding author}

关键词：Bevacizumab ; Cetuximab ; Panitumumab ; Meta-analysis ; Survival ; Progression-free survival

刊名：European Journal of Cancer

出版年：2016

按检索点细分(211)

题名(99)

关键词(71)

文摘(123)

按出版年细分(211)

2027年及以后(10)

2017年(3)

2016年(10)

2015年(18)

2013年(20)

2012年(24)

2011年(15)

2010年(25)

2009年(23)

2008年(23)

2007年(17)

2006年(5)

2005年(9)

2004年(3)

2000年及以前(6)

常见问题　|　交通位置　|　联系我们　|　OA远程办公

地址：北京市海淀区学院路29号邮编：100083

电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700